Kanceftri 125mg Injection
Marketer
Fortune Life Sciences Private Limited
Salt Composition
Ceftriaxone (125mg)
Overview Kanceftri 125mg Injection
Ceftazidime 125mg injection, a cephalosporin antibiotic, combats various bacterial infections. Its applications span diverse sites including the central nervous system (meningitis), respiratory system (pneumonia), ears, urinary tract, skin and soft tissues, musculoskeletal system, bloodstream, and cardiovascular system. Prophylactic use before surgery is also indicated. Administered intravenously or intramuscularly by a healthcare professional, dosage is determined individually. Consistent, evenly-spaced dosing, as directed, is crucial; premature cessation may result in recurrence or exacerbation of the infection. Common side effects encompass diarrhea, rash, altered liver function test results, and hematologic changes (eosinophilia, leukopenia, thrombocytopenia). Localized injection site reactions (erythema, pain) may occur transiently. Report persistent or bothersome side effects. Prior to treatment, disclose any antibiotic allergies, renal or hepatic impairment, and all concomitant medications to ensure safe and effective use.
Primary Ingredients of Kanceftri 125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Kanceftri 125mg Injection
Managing bacterial infections
Major Benefits of Kanceftri 125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Kanceftri 125mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Kanceftri 125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Kanceftri 125mg Injection works:
Kanceftri 125mg injection is a bacterial killer, functioning as an antibiotic by disrupting the formation of the bacteria's protective outer layer, the cell wall, essential for their survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Kanceftri 125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Kanceftri, 125mg, is considered safe for use during pregnancy. Research largely indicates minimal or negligible risk to the fetus.
Breast feedingCAUTION
The administration of Kanceftri 125mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against for the duration of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Kanceftri 125mg Injection may induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Kanceftri 125mg Injection poses no safety concerns for individuals with renal impairment; dosage modification is unnecessary. Nevertheless, disclosure of any pre-existing kidney conditions to your physician is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Kanceftri 125mg Injection cautiously, potentially requiring a modified dosage. Consult a physician for guidance. Dosage alteration for Kanceftri 125mg Injection is unnecessary for individuals with mild or moderate liver dysfunction.
What if you forget to take Kanceftri 125mg Injection :
Omit a dose of Kanceftri 125mg Injection? Seek your physician's advice.
Facts to Know About Kanceftri 125mg Injection
| Label | Value |
|---|---|
| Chemical Type | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
3,018 People bought this recently